Literature DB >> 32156203

Soluble ST2 Is Associated With New Epileptiform Abnormalities Following Nontraumatic Subarachnoid Hemorrhage.

W Taylor Kimberly1, Eric S Rosenthal1, India A Lissak1, Sahar F Zafar1, M Brandon Westover1, Riana L Schleicher1, Jennifer A Kim2, Thabele Leslie-Mazwi1,3, Christopher J Stapleton3, Aman B Patel3.   

Abstract

Background and Purpose- We evaluated the association between 2 types of predictors of delayed cerebral ischemia after nontraumatic subarachnoid hemorrhage, including biomarkers of the innate immune response and neurophysiologic changes on continuous electroencephalography. Methods- We studied subarachnoid hemorrhage patients that had at least 72 hours of continuous electroencephalography and blood samples collected within the first 5 days of symptom onset. We measured inflammatory biomarkers previously associated with delayed cerebral ischemia and functional outcome, including soluble ST2 (sST2), IL-6 (interleukin-6), and CRP (C-reactive protein). Serial plasma samples and cerebrospinal fluid sST2 levels were available in a subgroup of patients. Neurophysiologic changes were categorized into new or worsening epileptiform abnormalities (EAs) or new background deterioration. The association of biomarkers with neurophysiologic changes were evaluated using the Wilcoxon rank-sum test. Plasma and cerebrospinal fluid sST2 were further examined longitudinally using repeated measures mixed-effects models. Results- Forty-six patients met inclusion criteria. Seventeen (37%) patients developed new or worsening EAs, 21 (46%) developed new background deterioration, and 8 (17%) developed neither. Early (day, 0-5) plasma sST2 levels were higher among patients with new or worsening EAs (median 115 ng/mL [interquartile range, 73.8-197]) versus those without (74.7 ng/mL [interquartile range, 44.8-102]; P=0.024). Plasma sST2 levels were similar between patients with or without new background deterioration. Repeated measures mixed-effects modeling that adjusted for admission risk factors showed that the association with new or worsening EAs remained independent for both plasma sST2 (β=0.41 [95% CI, 0.09-0.73]; P=0.01) and cerebrospinal fluid sST2 (β=0.97 [95% CI, 0.14-1.8]; P=0.021). IL-6 and CRP were not associated with new background deterioration or with new or worsening EAs. Conclusions- In patients admitted with subarachnoid hemorrhage, sST2 level was associated with new or worsening EAs but not new background deterioration. This association may identify a link between a specific innate immune response pathway and continuous electroencephalography abnormalities in the pathogenesis of secondary brain injury after subarachnoid hemorrhage.

Entities:  

Keywords:  biomarkers; electroencephalography; ischemia; subarachnoid hemorrhage

Mesh:

Substances:

Year:  2020        PMID: 32156203      PMCID: PMC7123848          DOI: 10.1161/STROKEAHA.119.028515

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  39 in total

1.  Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage.

Authors:  Asita Sarrafzadeh; Florian Schlenk; Christine Gericke; Peter Vajkoczy
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

2.  Metabolic Correlates of the Ictal-Interictal Continuum: FDG-PET During Continuous EEG.

Authors:  Aaron F Struck; M Brandon Westover; Lance T Hall; Gina M Deck; Andrew J Cole; Eric S Rosenthal
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

3.  C-reactive protein and vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Flávio Ramalho Romero; Daniele Cristina Cataneo; Antonio José Maria Cataneo
Journal:  Acta Cir Bras       Date:  2014-05       Impact factor: 1.388

4.  Early detection of vasospasm after acute subarachnoid hemorrhage using continuous EEG ICU monitoring.

Authors:  P M Vespa; M R Nuwer; C Juhász; M Alexander; V Nenov; N Martin; D P Becker
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1997-12

Review 5.  The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease.

Authors:  Jens P Dreier
Journal:  Nat Med       Date:  2011-04-07       Impact factor: 53.440

6.  Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome.

Authors:  Jan Claassen; David Albers; J Michael Schmidt; Gian Marco De Marchis; Deborah Pugin; Christina Maria Falo; Stephan A Mayer; Serge Cremers; Sachin Agarwal; Mitchell S V Elkind; E Sander Connolly; Vanja Dukic; George Hripcsak; Neeraj Badjatia
Journal:  Ann Neurol       Date:  2014-05-16       Impact factor: 10.422

Review 7.  The role of spreading depolarization in subarachnoid hemorrhage.

Authors:  R Sánchez-Porras; Z Zheng; E Santos; M Schöll; A W Unterberg; O W Sakowitz
Journal:  Eur J Neurol       Date:  2013-03-29       Impact factor: 6.089

8.  Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage.

Authors:  Chunxiao Ma; Wei Zhou; Zhaoyue Yan; Mingqi Qu; Xingyao Bu
Journal:  J Neurol Sci       Date:  2015-10-14       Impact factor: 3.181

9.  Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms.

Authors:  Hung-Wen Kao; Kwo-Whei Lee; Chen-Ling Kuo; Ching-Shan Huang; Wan-Min Tseng; Chin-San Liu; Ching-Po Lin
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

10.  Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection.

Authors:  Stephen J Hopkins; Catherine J McMahon; Navneet Singh; James Galea; Margaret Hoadley; Sylvia Scarth; Hiren Patel; Andy Vail; Sharon Hulme; Nancy J Rothwell; Andrew T King; Pippa J Tyrrell
Journal:  J Neuroinflammation       Date:  2012-11-23       Impact factor: 8.322

View more
  5 in total

Review 1.  The Utility of Quantitative EEG in Detecting Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Hae Young Baang; Hsin Yi Chen; Alison L Herman; Emily J Gilmore; Lawrence J Hirsch; Kevin N Sheth; Nils H Petersen; Sahar F Zafar; Eric S Rosenthal; M Brandon Westover; Jennifer A Kim
Journal:  J Clin Neurophysiol       Date:  2022-03-01       Impact factor: 2.590

Review 2.  Aneurysmal Subarachnoid Hemorrhage.

Authors:  David Y Chung; Mohamad Abdalkader; Thanh N Nguyen
Journal:  Neurol Clin       Date:  2021-03-31       Impact factor: 3.806

Review 3.  Challenges and Opportunities in Multimodal Monitoring and Data Analytics in Traumatic Brain Injury.

Authors:  Brandon Foreman; India A Lissak; Neha Kamireddi; Dick Moberg; Eric S Rosenthal
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-02       Impact factor: 5.081

Review 4.  Role of Interleukin-1 Receptor-Like 1 (ST2) in Cerebrovascular Disease.

Authors:  Cristina Sastre; Matthew B Bevers; W Taylor Kimberly
Journal:  Neurocrit Care       Date:  2021-07-06       Impact factor: 3.210

Review 5.  Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.

Authors:  Yun Sun; Yankai Wen; Luxi Wang; Liang Wen; Wendong You; Shuang Wei; Lin Mao; Hao Wang; Zuobing Chen; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.